
BioHarvest Sciences (BHST) Earnings Dates & Reports
BioHarvest Sciences (BHST) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.10
Actual EPS-$0.10
EarningsMeet
BioHarvest Sciences (BHST) Earnings
View the latest BioHarvest Sciences (BHST) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in BioHarvest Sciences (BHST)
Order type
Buy in
Order amount
Est. shares
0 shares
BioHarvest Sciences (BHST) Earnings per Share (EPS) History
Signup for full accessBrowse free
BioHarvest Sciences (BHST) Latest Earnings
The value each BHST share was expected to gain vs. the value each share gained.
BioHarvest Sciences (BHST) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.10. This exceeded analysts' expectations of -$0.10 by 0.00%, marking a Meet.
For comparison, BioHarvest Sciences reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
BioHarvest Sciences (BHST) Earnings History
BioHarvest Sciences (BHST) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the BioHarvest Sciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|
BioHarvest Sciences (BHST) Earnings FAQs
BioHarvest Sciences (BHST) last reported earnings on Mar 31, 2026 for Q4 2025, posting an EPS of -$0.10, which Meet the estimate of -$0.10 by 0.00%.
For Q4 2025, BioHarvest Sciences (BHST) reported an EPS of -$0.10, missing analysts' estimate of -$0.10 by 0.00%.
For Q4 2025, BioHarvest Sciences (BHST) Meet expectations with an actual EPS of -$0.10 vs. an estimated EPS of -$0.10.
Following the last earnings report on Mar 31, 2026, BioHarvest Sciences (BHST)'s stock price moved — from — to —.
The next BioHarvest Sciences (BHST) earnings call is scheduled for Mar. 31, 2026, where executives will discuss financial results and outlook.